1. Home
  2. Browse Decisions
  3. F.3d
  4. 881 F.3d
  5. 881 F.3d 1334 (2018)
 

ABBVIE INC. v. MEDIMMUNE LTD.

2017-1689.

881 F.3d 1334 (2018)

ABBVIE INC., AbbVie Biotechnology, Ltd., Plaintiffs-Appellants v. MEDIMMUNE LIMITED, Defendant-Appellee.

United States Court of Appeals, Federal Circuit.

Decided February 5, 2018.

Attorney(s) appearing for the Case

JEFFREY I. WEINBERGER , Munger, Tolles & Olson LLP, Los Angeles, CA, argued for plaintiffs-appellants. Also represented by HEATHER E. TAKAHASHI ; GINGER ANDERS , Washington, DC; DAVID PENN FRAZIER , MICHAEL A. MORIN , Latham & Watkins LLP, Washington, DC.

DAVID I. BERL , Williams & Connolly LLP, Washington, DC, argued for defendant-appellee. Also represented by THOMAS S. FLETCHER , SHAUN PATRICK MAHAFFY.

Before Prost, Chief Judge, Dyk, and Chen, Circuit Judges.

AbbVie, Inc., and AbbVie Biotechnology Ltd. ("AbbVie") filed suit in the Eastern District of Virginia against MedImmune Limited ("MedImmune"), seeking a declaratory judgment that U.S. Patent No. 6,248,516 ("the '516 patent") is invalid. The district court determined that it lacked jurisdiction under the Declaratory Judgment Act...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases